MicroRNAs add a new dimension to cardiovascular disease.
作者信息
Small Eric M, Frost Robert J A, Olson Eric N
机构信息
UT Southwestern Medical Center, 5323 Harry Hines Blvd, NA8.602, Dallas, TX 75390-9148, USA.
出版信息
Circulation. 2010 Mar 2;121(8):1022-32. doi: 10.1161/CIRCULATIONAHA.109.889048.
Abstract
摘要
相似文献
1
MicroRNAs add a new dimension to cardiovascular disease.
Circulation. 2010 Mar 2;121(8):1022-32. doi: 10.1161/CIRCULATIONAHA.109.889048.
2
Review focus on the role of microRNA in cardiovascular biology and disease.
Cardiovasc Res. 2012 Mar 15;93(4):543-4. doi: 10.1093/cvr/cvs085. Epub 2012 Feb 7.
3
Functions of microRNAs in cardiovascular biology and disease.
Annu Rev Physiol. 2013;75:69-93. doi: 10.1146/annurev-physiol-030212-183737. Epub 2012 Nov 13.
4
MiR-222 in Cardiovascular Diseases: Physiology and Pathology.
Biomed Res Int. 2017;2017:4962426. doi: 10.1155/2017/4962426. Epub 2017 Jan 3.
5
MicroRNAs and the heart: small things do matter.
Curr Top Med Chem. 2013;13(2):216-30. doi: 10.2174/1568026611313020009.
6
Introduction to the series on microRNAs in the cardiovascular system.
Circ Res. 2012 Feb 3;110(3):481-2. doi: 10.1161/CIRCRESAHA.111.257311.
7
Circadian rhythmic aspects of human cardiovascular function: a review by chronobiologic statistical methods.
Chronobiologia. 1976 Oct-Dec;3(4):337-71.
8
Implication of microRNAs in the cardiovascular system.
Curr Opin Pharmacol. 2008 Apr;8(2):181-8. doi: 10.1016/j.coph.2007.12.013. Epub 2008 Feb 19.
9
MicroRNA in cardiovascular biology and disease.
Adv Clin Exp Med. 2017 Aug;26(5):865-874. doi: 10.17219/acem/62915.
10
[Adrenergic receptors in the cardiovascular system (their topography, function and regulation)].
Kardiologiia. 1989 Jul;29(7):124-8.
引用本文的文献
1
Engineering Nanoparticles and Bioscaffolds for Targeted microRNA Delivery in Cardiovascular Regeneration-A Comprehensive Review.
FASEB J. 2025 Jul 31;39(14):e70871. doi: 10.1096/fj.202501226RR.
2
MicroRNAs' Impact on Heart Diseases.
Int J Mol Sci. 2025 Jun 10;26(12):5566. doi: 10.3390/ijms26125566.
3
Genetic Associations of Plasminogen Activator Inhibitor-1-Related miRNA Variants with Coronary Artery Disease.
Int J Mol Sci. 2024 Oct 27;25(21):11528. doi: 10.3390/ijms252111528.
4
MicroRNAs and other biomarkers of atrial fibrillation in ischemic stroke patients.
Medicine (Baltimore). 2024 Oct 25;103(43):e40165. doi: 10.1097/MD.0000000000040165.
5
MicroRNA-503 Suppresses Oral Mucosal Fibroblast Differentiation by Regulating RAS/RAF/MEK/ERK Signaling Pathway.
Biomolecules. 2024 Oct 5;14(10):1259. doi: 10.3390/biom14101259.
6
Hypoxia-responsive zinc finger E-box-binding homeobox 2 (ZEB2) regulates a network of calcium-handling genes in the injured heart.
Cardiovasc Res. 2024 Dec 4;120(15):1869-1883. doi: 10.1093/cvr/cvae163.
7
Identification of miR-1 and miR-499 in chronic atrial fibrillation by bioinformatics analysis and experimental validation.
Front Cardiovasc Med. 2024 Aug 16;11:1400643. doi: 10.3389/fcvm.2024.1400643. eCollection 2024.
8
Deep Diving Into the Cardiovascular Health Paradox: A Journey Towards Personalized Prevention.
Public Health Rev. 2024 Jul 17;45:1606879. doi: 10.3389/phrs.2024.1606879. eCollection 2024.
9
Cardiovascular Disease and miRNAs: Possible Oxidative Stress-Regulating Roles of miRNAs.
Antioxidants (Basel). 2024 May 27;13(6):656. doi: 10.3390/antiox13060656.
10
Resident vascular Sca1 progenitors differentiate into endothelial cells in vascular remodeling via miR-145-5p/ERG signaling pathway.
iScience. 2024 May 22;27(6):110080. doi: 10.1016/j.isci.2024.110080. eCollection 2024 Jun 21.
本文引用的文献
1
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.
J Clin Invest. 2009 Sep;119(9):2772-86. doi: 10.1172/JCI36154. Epub 2009 Aug 10.
2
Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2.
J Biol Chem. 2009 Nov 27;284(48):33161-8. doi: 10.1074/jbc.M109.020925. Epub 2009 Aug 31.
3
MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury.
Genes Dev. 2009 Sep 15;23(18):2166-78. doi: 10.1101/gad.1842409. Epub 2009 Aug 31.
4
Plasma miR-208 as a biomarker of myocardial injury.
Clin Chem. 2009 Nov;55(11):1944-9. doi: 10.1373/clinchem.2009.125310. Epub 2009 Aug 20.
5
Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster.
J Clin Invest. 2009 Sep;119(9):2634-47. doi: 10.1172/JCI38864. Epub 2009 Aug 17.
6
Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure.
Circ Res. 2009 Sep 11;105(6):585-94. doi: 10.1161/CIRCRESAHA.109.200451. Epub 2009 Aug 13.
7
miR-145 and miR-143 regulate smooth muscle cell fate and plasticity.
Nature. 2009 Aug 6;460(7256):705-10. doi: 10.1038/nature08195. Epub 2009 Jul 5.
8
miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy.
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12103-8. doi: 10.1073/pnas.0811371106. Epub 2009 Jul 2.
9
MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.
Circ Res. 2009 Jul 17;105(2):158-66. doi: 10.1161/CIRCRESAHA.109.197517. Epub 2009 Jun 18.
10
MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.
Science. 2009 Jun 26;324(5935):1710-3. doi: 10.1126/science.1174381. Epub 2009 May 21.
Zotero 插件